1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TCF4 CTRPv2 pan-cancer AAC 0.23 3e-10
mRNA GGA2 CTRPv2 pan-cancer AAC 0.23 8e-10
mRNA RHOH CTRPv2 pan-cancer AAC 0.25 1e-09
mRNA CCDC117 CTRPv2 pan-cancer AAC 0.21 3e-09
mRNA POU2AF1 CTRPv2 pan-cancer AAC 0.23 3e-09
mRNA TOR3A CTRPv2 pan-cancer AAC 0.21 4e-09
mRNA IGF2BP2 CTRPv2 pan-cancer AAC -0.22 4e-09
mRNA FAM214A CTRPv2 pan-cancer AAC 0.21 7e-09
mRNA PIK3CB CTRPv2 pan-cancer AAC -0.19 1e-08
mRNA ZNF532 CTRPv2 pan-cancer AAC 0.21 2e-08
Download CSV